In Brief: Diametrics Medical
This article was originally published in The Gray Sheet
Executive Summary
Diametrics Medical: Completes acquisition of Biomedical Sensors Ltd. unit of Pfizer for $1.5 mil. cash and a six-year promissory note valued at $7.3 mil., the firm announces Nov. 7. Diametrics previously announced it was negotiating for the purchase ("The Gray Sheet" Oct. 28, In Brief). BSL, which becomes a subsidiary of Diametrics, will continue to be headed by Roy Johnson, president. Diametrics expects the addition of BSL's line of indwelling blood and tissue monitoring systems to double its sales and "significantly" enhance earnings potential...